Below is note from Tal Behar, Co-Founder & President of the Precision Medicine World Conference (PMWC), on the PMWC’s new award recognizing the massive contributions and far-reaching vision of genetic scientist J. Craig Venter. Few scientists have changed the trajectory of biology as boldly as he. From helping bring the first draft human genome into view to advancing synthetic biology through the first self-replicating synthetic bacterial cell, his work pushed genomics from discovery into a new era of biological design.
“At PMWC 2027 (January 27-29), we are proud to launch the J. Craig Venter Visionary Award, created to recognize scientists whose work embodies that same spirit of bold, field-defining innovation.”
“We are honored to announce Nobel Laureate Emmanuelle Charpentier as the inaugural recipient. The award will be presented by Heather Kowalski, Acting Chief Executive Officer at the J. Craig Venter Institute.”
“Dr. Charpentier’s co-development of CRISPR-Cas9 genome editing transformed bacterial immune biology into one of the most powerful tools in modern science. Her work opened new possibilities for gene-based therapies, diagnostics, and precision medicine.”
“It is hard to imagine a more fitting first recipient for an award named in honor of J. Craig Venter, a scientist whose career was defined by challenging the limits of what biology can become.”
“Join us at PMWC 2027 as we celebrate this landmark award presentation and the next era of genome engineering.”
Meeting Registration: https://pmwcintl.com/tickets/
–Tal Behar, Co-Founder & President, PMWC